Phio Pharmaceuticals Corp. (PHIO)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $95k
- Sep 7 · Plan not stated
- Form 4 sales
- 3
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
0
Routine
3
Plan not stated
0
No plan
0
Unusual
Timeline
- 1 Form 4 salePlan not statedMay 2, 2013 2013
Sold 1.1M shares at $0.19 ($209k)
Galena Biopharma, Inc., 10% owner
Sold 3.2% of holdings ($6.5M position)32.4M shares leftFirst sale on recordFiling
- 2 Form 4 salePlan not statedSep 1, 2017 +1583 days
Sold 23,200 shares at $0.57 ($13k)
Eliseev Alexey, Chief Business Officer
Sold 2% of holdings ($656k position)1.1M shares leftFirst sale on recordFiling
- 3 Form 4 salePlan not statedSep 7, 2017 +6 days
Sold 176,800 shares at $0.54 ($95k)
Eliseev Alexey, Chief Business Officer
Sold 15.7% of holdings ($608k position)950,312 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (3)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2017 | Sep 7, 2017 | Eliseev Alexey | PHIO | Chief Business Officer | Form 4 sale | 176,800 | $95k | 15.7% | Plan not stated | SEC |
| Sep 1, 2017 | Sep 1, 2017 | Eliseev Alexey | PHIO | Chief Business Officer | Form 4 sale | 23,200 | $13k | 2.0% | Plan not stated | SEC |
| May 2, 2013 | May 2, 2013 | Galena Biopharma, Inc. | PHIO | 10% owner | Form 4 sale | 1.1M | $209k | 3.2% | Plan not stated | SEC |